RETRACTED: PS 124 - Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (Psc) in Individuals with Inflammatory Bowel Disease
| Autor: | J. Oshiomogo, J. Heatherington, Gilaad G. Kaplan, Remo Panaccione, Subrata Ghosh, Bertus Eksteen |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Hepatology business.industry Inflammation medicine.disease Inflammatory bowel disease Gastroenterology Primary sclerosing cholangitis Vedolizumab 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Immunology Medicine 030211 gastroenterology & hepatology Dosing medicine.symptom business medicine.drug |
| Zdroj: | Journal of Hepatology. 64:S199 |
| ISSN: | 0168-8278 |
| DOI: | 10.1016/s0168-8278(16)01707-4 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect